Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
1.
BMC Infect Dis ; 20(1): 761, 2020 Oct 16.
Artigo em Inglês | MEDLINE | ID: mdl-33066740

RESUMO

BACKGROUND: Device-associated health care-associated infections (DA-HAIs) in intensive care unit (ICU) patients constitute a major therapeutic issue complicating the regular hospitalisation process and having influence on patients' condition, length of hospitalisation, mortality and therapy cost. METHODS: The study involved all patients treated > 48 h at ICU of the Medical University Teaching Hospital (Poland) from 1.01.2015 to 31.12.2017. The study showed the surveillance and prevention of DA-HAIs on International Nosocomial Infection Control Consortium (INICC) Surveillance Online System (ISOS) 3 online platform according to methodology of the INICC multidimensional approach (IMA). RESULTS: During study period 252 HAIs were found in 1353 (549F/804M) patients and 14,700 patient-days of hospitalisation. The crude infections rate and incidence density of DA-HAIs was 18.69% and 17.49 ± 2.56 /1000 patient-days. Incidence density of ventilator-associated pneumonia (VAP), central line-associated bloodstream infection (CLA-BSI) and catheter-associated urinary tract infection (CA-UTI) per 1000 device-days were 12.63 ± 1.49, 1.83 ± 0.65 and 6.5 ± 1.2, respectively. VAP(137) constituted 54.4% of HAIs, whereas CA-UTI(91) 36%, CLA-BSI(24) 9.6%.The most common pathogens in VAP and CA-UTI was multidrug-resistant (MDR) Acinetobacter baumannii (57 and 31%), and methicillin-resistant Staphylococcus epidermidis (MRSE) in CLA-BSI (45%). MDR Gram negative bacteria (GNB) 159 were responsible for 63.09% of HAIs. The length of hospitalisation of patients with a single DA-HAI at ICU was 21(14-33) days, while without infections it was 6.0 (3-11) days; p = 0.0001. The mortality rates in the hospital-acquired infection group and no infection group were 26.1% vs 26.9%; p = 0.838; OR 0.9633;95% CI (0.6733-1.3782). Extra cost of therapy caused by one ICU acquired HAI was US$ 11,475/Euro 10,035. Hand hygiene standards compliance rate was 64.7%, while VAP, CLA-BSI bundles compliance ranges were 96.2-76.8 and 29-100, respectively. CONCLUSIONS: DA-HAIs was diagnosed at nearly 1/5 of patients. They were more frequent than in European Centre Disease Control report (except for CLA-BSI), more frequent than the USA CDC report, yet less frequent than in limited-resource countries (except for CA-UTI). They prolonged the hospitalisation period at ICU and generated substantial additional costs of treatment with no influence on mortality. The Acinetobacter baumannii MDR infections were the most problematic therapeutic issue. DA-HAIs preventive methods compliance rate needs improvement.


Assuntos
Infecções por Acinetobacter/epidemiologia , Acinetobacter baumannii/genética , Infecções Relacionadas a Cateter/epidemiologia , Hospitais Universitários/economia , Controle de Infecções/métodos , Unidades de Terapia Intensiva/economia , Staphylococcus aureus Resistente à Meticilina/genética , Pneumonia Associada à Ventilação Mecânica/epidemiologia , Infecções Estafilocócicas/epidemiologia , Infecções Urinárias/epidemiologia , Infecções por Acinetobacter/economia , Infecções por Acinetobacter/microbiologia , Infecções por Acinetobacter/prevenção & controle , Adulto , Idoso , Idoso de 80 Anos ou mais , Infecções Relacionadas a Cateter/economia , Infecções Relacionadas a Cateter/microbiologia , Infecções Relacionadas a Cateter/prevenção & controle , Farmacorresistência Bacteriana Múltipla , Feminino , Higiene das Mãos/normas , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Pneumonia Associada à Ventilação Mecânica/economia , Pneumonia Associada à Ventilação Mecânica/microbiologia , Pneumonia Associada à Ventilação Mecânica/prevenção & controle , Polônia/epidemiologia , Reação em Cadeia da Polimerase , Estudos Prospectivos , Infecções Estafilocócicas/economia , Infecções Estafilocócicas/microbiologia , Infecções Estafilocócicas/prevenção & controle , Infecções Urinárias/economia , Infecções Urinárias/microbiologia , Infecções Urinárias/prevenção & controle
2.
Ginekol Pol ; 86(1): 53-61, 2015 Jan.
Artigo em Polonês | MEDLINE | ID: mdl-25775876

RESUMO

OBJECTIVE: The aim of the study was to analyze the clinical reasons for hospitalization due to gynecological causes of adolescent girls and young women. METHODS: We reviewed clinical data on reasons for hospitalization, treatment methods, and histopathological diagnosis in adolescent girls and young women hospitalized at the Second Department of Gynecology Medical University of Lublin, between January 2003 and December 2012. Methods of conservative or surgical treatment, as well as their clinical effectiveness, have been discussed. RESULTS: Over the analyzed period of time, we identified 334 patients at the age between 8 and 20 years, which accounted for 1.61% of all hospitalized women during that time. Rating these patients by age, we found the following: 1 patient < 9 years old, 2 patients aged 10-11 years, 38 patients aged 12-14 years, 128 patients aged 15-17 years and 165 patients aged 17-19 years old. The main clinical reasons for hospitalization of adolescents and young women due to gynecological causes were: ovarian cysts (138 cases; 41.3%), menstrual disorders (46 cases; 13.7%), pregnancy complications (35 cases; 10.5%), and congenital Müllerian anomalies (33 cases; 9.9%). The remaining patients (24.6%) were admitted due to suspicion of ovarian cyst (22 cases; 6.6%), cervical erosion (15 cases; 4.5%), juvenile metrorrhagia (15 cases; 4.5%), and vulvar diseases (8 cases; 2.4%). CONCLUSIONS: Adolescent girls and young women are rarely admitted to gynecological departments. Nevertheless, they present a clinical challenge. Proper diagnosis using advanced visualization methods, along with modern pharmacotherapy accounts for the final therapeutic success.


Assuntos
Doenças dos Genitais Femininos/epidemiologia , Doenças dos Genitais Femininos/terapia , Hospitalização/estatística & dados numéricos , Distúrbios Menstruais/epidemiologia , Distúrbios Menstruais/terapia , Adolescente , Fatores Etários , Feminino , Ginecologia/normas , Humanos , Polônia/epidemiologia , Estudos Retrospectivos , Fatores de Risco , Índice de Gravidade de Doença , Adulto Jovem
3.
Prz Menopauzalny ; 13(6): 313-29, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26327873

RESUMO

Bladder storage symptoms have a severe impact on many areas as regards the quality of life including health-related, social, psychological and working functions. Pharmacotherapy of lower urinary tract stores (LUTS) has been developed to optimize neural control of the lower urinary tract in pathologic states. The bladder can be overactive or underactive. Overactive bladder (OAB) is highly prevalent and is associated with considerable morbidity, especially in aging population. Therefore, an effective treatment of OAB must result in a meaningful reduction in urinary symptoms. Pharmacotherapy for the OAB must be individualized based on the degree of bother, medication side-effect profile, concomitant comorbidities and current medication regimen. Antimuscarinic agents will continue to represent the current gold standard for the first-line pharmacological management of OAB. Alternatively to antimuscarinic therapy, ß3-adrenergic receptor agonists, due to their efficacy and favorable adverse event profile, are a novel and attractive option of pharmacological treatment of overactive bladder symptoms. A combination of selective antimuscarinic and ß3-adrenergic receptor agonists, agents with the different mechanism of action, gives a new treatment option for the patient with OAB according to its harms profile. A number of putative novel therapeutic agents is under clinical evaluations that may ultimately provide alternative or combination treatment options for OAB in the nearest future.

4.
Ginekol Pol ; 83(4): 316-8, 2012 Apr.
Artigo em Polonês | MEDLINE | ID: mdl-22712267

RESUMO

Nomegestrol acetate (NOMAC) combined with E2 (Zoely) is a monophasic oral contraceptive (OC) which safety and efficacy was confirmed in a number of level I evidence clinical trials. Zoely is highly effective OC, especially in overweight and obese patients, with good cycle control, safe and well tolerated. NOMAC/E2 combination causes no or minimal weight gain and is characterized by minimal influence on bone mineral density or blood pressure and presence of acne. Moreover lipids profile, carbohydrates metabolism, haemostasis and endocrine glands functioning were not affected. High tolerance and acceptance of NOMAC/E2 combination by women, low adverse event profile, fast recovery of ovarian activity and ovulation is a reasonable treatment tool in everyday practice.


Assuntos
Anticoncepcionais Orais Combinados/administração & dosagem , Anticoncepcionais Orais Sintéticos/administração & dosagem , Estradiol/administração & dosagem , Megestrol/administração & dosagem , Norpregnadienos/administração & dosagem , Guias de Prática Clínica como Assunto , Adulto , Feminino , Ginecologia/normas , Humanos , Capacitação em Serviço/normas , Programas Nacionais de Saúde/normas , Obstetrícia/normas , Ovulação/efeitos dos fármacos , Polônia , Adulto Jovem
5.
Ginekol Pol ; 83(6): 417-23, 2012 Jun.
Artigo em Polonês | MEDLINE | ID: mdl-22880460

RESUMO

OBJECTIVES: The aim of the study was to develop an optimal educational model for contraceptive counseling, to analyze conditions influencing choice of hormonal contraception, to study patients' opinions on present, planned and proposed contraceptive methods and to link these data with socioeconomic and demographic conditions. MATERIALS AND METHODS: One thousand eight hundred fifty women (mean age 26.8 +/- 5.9 yrs) willing to use hormonal contraception were presented with essential information on combined hormonal contraception and asked to fill the anonymous questionnaire investigating factors influencing contraceptive choice and patients' opinion on alternative forms of birth regulation. The study was conducted in selected 185 centers in Poland and was a part of a larger survey (CHOICE) conducted on 11 216 women in Europe and Israel. RESULTS: Majority of the studied women were in stable relationship (85,5%), had higher or incomplete higher education (54.8%) and permanent job (54%). The purpose of the visit was to start/change contraception (64.2%), a routine gynecologic check-up (36.7%) or the need for a prescription for the continued contraceptive medication (18.7%). The most commonly used contraceptive methods were oral contraceptive pills (OCP 38.7%) and condom (24.9%). Majority of women highly valued contraceptive counseling and more than 90% were eager to get familiarized with information leaflets. Before the counseling majority of subjects stated that were convinced to use OCP (52.7%; major advantages named: easy to use, favorable bleeding profile, amelioration of menstrual discomfort, comfortable, discrete) and contraceptive patch (22%; major advantages named: applied once a week, comfortable, simple, low risk for noncompliance, favorable bleeding profile). After the counseling there was an increase in proportion of women interested in contraceptive hormonal ring (by 19%; major advantages named: applied once a month, comfortable, very low risk for noncompliance, high efficacy and positive recommendation from a physician). In 58 women no hormonal contraception was recommended, predominantly due to medical contraindications. CONCLUSIONS: Appropriate patient counseling on all forms of combined hormonal contraception, with special attention paid to benefits and safety issues, suited to women's expectations and education is fundamental for the selection of an optimal birth control method.


Assuntos
Comportamento Contraceptivo/estatística & dados numéricos , Anticoncepção/estatística & dados numéricos , Anticoncepcionais Orais Combinados/administração & dosagem , Aconselhamento/organização & administração , Conhecimentos, Atitudes e Prática em Saúde , Educação de Pacientes como Assunto/estatística & dados numéricos , Adulto , Comportamento de Escolha , Anticoncepção/psicologia , Comportamento Contraceptivo/psicologia , Esquema de Medicação , Feminino , Humanos , Polônia/epidemiologia , Atenção Primária à Saúde/organização & administração , Relações Profissional-Paciente , Saúde da Mulher/estatística & dados numéricos , Adulto Jovem
6.
J Urol ; 186(1): 180-4, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21575972

RESUMO

PURPOSE: Mid urethral slings are effective surgical treatment for stress urinary incontinence. However, 5% to 20% of patients still experience surgical failure with clinically significant recurrent or persistent stress urinary incontinence. Since a subset of these failures may be caused by improper tape position, we elucidated whether additional paraurethral fixation of a tape to prevent displacement during tensioning could improve the transobturator sling outcome. MATERIALS AND METHODS: The study was done in 463 patients with stress urinary incontinence who were randomly allocated to treatment with a standard transobturator intravaginal monofilament sling procedure (232) or to an intravaginal transobturator monofilament sling with additional 2-point tape fixation (231). Another 2 absorbable sutures parallel to the urethra were added to fix the tape and prevent displacement during tape tensioning. Outcome was assessed by a cough test and a 1-hour pad test at 12 months. RESULTS: Clinical efficacy of the procedure with fixation was significantly higher with 195 women (95.12%) cured or improved compared to the 199 (88.73%) cured or improved with the standard sling (chi-square 5.71, p = 0.0169). There was no increase in intraoperative or postoperative complications. Also, among patients with intrinsic sphincter deficiency we noted a significantly better outcome in the fixation group than in the control group, that is 39 of 41 patients (95.1%) cured or improved vs 31 of 42 (73.8%) (chi-square 10.65, p = 0.0011). CONCLUSIONS: Tape fixation significantly increases the clinical efficacy of the transobturator sling, especially in patients with intrinsic sphincter deficiency.


Assuntos
Slings Suburetrais , Incontinência Urinária por Estresse/cirurgia , Feminino , Humanos , Pessoa de Meia-Idade , Implantação de Prótese/métodos , Indução de Remissão , Técnicas de Sutura , Procedimentos Cirúrgicos Urológicos/métodos
7.
Ginekol Pol ; 81(1): 24-30, 2010 Jan.
Artigo em Polonês | MEDLINE | ID: mdl-20232695

RESUMO

OBJECTIVES: The purpose of this work was to evaluate the quality of life of patients suffering from urge urinary incontinence resistant to anticholinergic therapy treated with intradetrusical injections of 200 U botulinum toxin A. MATERIALS AND METHODS: The study group consisted of 10 female patients who were diagnosed with urge urinary incontinence. Standard King's questionnaire was used for the assessment of the change in the quality of life after treatment. Questionnaires were filled in by all patients before the treatment and during control visits, 3 months after the injection of botulinum toxin A. RESULTS: Statistically significant improvement in the quality of life for the majority of the domains of King's questionnaire (except the evaluation of urinary incontinence impact on the general health condition and social relations) was observed in 7 out of 10 patients subjected to botulinum toxin therapy (p < 0.05). CONCLUSIONS: Based on the results of this study we can conclude that treatment of patients with urge urinary incontinence not responding to classical anticholinergic treatment with botulinum toxin causes a significant improvement in the quality of their life.


Assuntos
Toxinas Botulínicas Tipo A/administração & dosagem , Fármacos Neuromusculares/administração & dosagem , Qualidade de Vida , Incontinência Urinária/tratamento farmacológico , Adulto , Feminino , Humanos , Injeções Intralesionais , Pessoa de Meia-Idade , Contração Muscular/efeitos dos fármacos , Inquéritos e Questionários , Resultado do Tratamento , Bexiga Urinária/efeitos dos fármacos , Urodinâmica/efeitos dos fármacos , Saúde da Mulher
8.
Ginekol Pol ; 81(7): 493-500, 2010 Jul.
Artigo em Polonês | MEDLINE | ID: mdl-20825049

RESUMO

AIM: Surgical procedures using synthetic implants are currently considered as the most efficient therapy for stress urinary incontinence (SUI) and pelvic organ prolapse (POP). Insertion of the tape or mesh causes enhanced collagen synthesis that largely affects the biomechanical property of the implant. This process is significantly modulated by estrogens and improper wound healing and treatment failure may result in hypoestrogenism. The aim of the study was to assess the rate of collagen type II synthesis by pubocervical fascia fibroblasts cultured with polypropylene meshes in the presence of estrogens and tamoxifen. MATERIAL AND METHODS: Fibroblasts were obtained from pubo-cervical fascia sampled from a 52-year-old premenopausal woman who underwent surgical treatment for SUI and cultured with monofilament or multifilament polypropylene meshes in the presence of 17B-estradiol, estriol, daidzein or tamoxifen. The cultures were run for 216 hr and the media were replaced every 72hr N-terminal propeptide of type III procollagen (PIIINP) was used as a marker of collagen type III synthesis. Its concentration in the media was measured by radioimmunoassay Pubocervical fascia fibroblast cultured with monofilament or multifilament meshes are capable of collagen type III synthesis. Following treatment with estradiol or tamoxifen, the highest PIIINP concentrations were observed after 72 hr whereas in case of estriol, daidzein or no treatment after 144hr of culture, regardless of the type of mesh used. RESULTS: Only in cultures containing monofilament mesh and stimulated with estriol the high rate of collagen type III synthesis persisted until the end of the experiment. Paradoxically the highest total production of PIIINP was observed in culture treated with tamoxifen, both for multifilament and monofilament meshes. CONCLUSION: The rate of collagen type III synthesis by pubocervical fascia fibroblast cultured with polypropylene meshes is subjected to modulation by estrogens and antiestrogens.


Assuntos
Colágeno Tipo III/biossíntese , Estradiol/farmacologia , Fibroblastos/efeitos dos fármacos , Polipropilenos/metabolismo , Tamoxifeno/farmacologia , Incontinência Urinária por Estresse/metabolismo , Incontinência Urinária por Estresse/cirurgia , Meios de Cultivo Condicionados , Estradiol/administração & dosagem , Fáscia/efeitos dos fármacos , Fáscia/patologia , Feminino , Humanos , Pessoa de Meia-Idade , Telas Cirúrgicas , Tamoxifeno/administração & dosagem
9.
Ginekol Pol ; 80(1): 63-75, 2009 Jan.
Artigo em Polonês | MEDLINE | ID: mdl-19323063

RESUMO

Recent epidemiologic studies indicate that use of combined oral contraception is associated with a increase in the incidence of cardiovascular disease (venous thromboembolism, pulmonary embolism, myocardial infarction and stroke). The risk of cardiovascular disease is strongly related to estrogen dose, progestogen type and other factors for example thrombogenic mutations and cigarette smoking among female over age 35. The progestogen only contraception is safe alternative to combined hormonal contraception. Progestogen only pill (POP) has different levels of action (local and/or central) which may vary from one drug to another. As for the cardiovascular disease risk, progestogens are not considered to be risk factors. Desogestrel containing POP is advised in the following cases: bad tolerance of exogenous oestrogens; in order to counteract an endogenous hyperoestrogenosis; medical, metabolic or cardiovascular contraindications to estroprogestogen contraception. Lastly, POP should be used as a prime contraception in some particular situations (breast feeding, endometriosis, adenomyosis, cigarette smoking, contraception for older women). These recommendations present the actual system of care in that population of women in Poland.


Assuntos
Doenças Cardiovasculares/prevenção & controle , Anticoncepcionais Orais Sintéticos/administração & dosagem , Desogestrel/administração & dosagem , Progestinas/administração & dosagem , Saúde da Mulher , Fatores Etários , Anticoncepcionais Orais/normas , Anticoncepcionais Orais Sintéticos/normas , Desogestrel/normas , Feminino , Humanos , Capacitação em Serviço/normas , Programas Nacionais de Saúde/normas , Polônia , Progestinas/normas , Garantia da Qualidade dos Cuidados de Saúde/normas , Fatores de Risco , Sociedades Médicas/normas , Serviços de Saúde da Mulher/organização & administração
10.
Ginekol Pol ; 79(10): 715-23, 2008 Oct.
Artigo em Polonês | MEDLINE | ID: mdl-19058529

RESUMO

The development of steroid-releasing vaginal rings over the past three decades is reviewed to illustrate the role of this device as an effective hormonal contraceptive for women. NuvaRing is a combined contraceptive vaginal ring that releases constant low doses of ethinylestradiol and etonogestrel. The soft flexible combined ring is inserted in the vagina for three weeks and removed for seven days to allow withdrawal bleeding with no serious side-effects. Maximum levels of EE and ENG with NuvaRing were 30% and 40%, respectively, of those seen with the COC. Because ENG bioavailability was higher following vaginal administration, the systemic progestogen exposures were comparable with the oral contraceptives. NuvaRing has been shown to be safe and effective, with high levels of user compliance, acceptance and patient satisfaction.


Assuntos
Anticoncepção/métodos , Anticoncepcionais Femininos/uso terapêutico , Conhecimentos, Atitudes e Prática em Saúde , Métodos Naturais de Planejamento Familiar/métodos , Desogestrel/análogos & derivados , Desogestrel/uso terapêutico , Combinação de Medicamentos , Etinilestradiol/uso terapêutico , Feminino , Ginecologia/normas , Humanos , Dispositivos Intrauterinos Medicados/tendências , Obstetrícia/normas , Educação de Pacientes como Assunto , Polônia/epidemiologia , Gravidez , Gravidez não Planejada , Saúde da Mulher
11.
Ginekol Pol ; 79(9): 638-52, 2008 Sep.
Artigo em Polonês | MEDLINE | ID: mdl-18939517

RESUMO

Vulvovaginal infection is the most common cause of gynecological problems in sexually active women. Few years ago it was not considered as serious disease which may cause major health implications. Currently we are aware that it implies life worsening, temporal indisposition, postoperative complications and even life threatening sepsis in patients hospitalized in Intensive Care Units. Knowledge about pharmacological properties of drugs used in treatment vulvovaginal candidiasis allows for tailoring therapy to each patient. Fluconazole is modern and up to date option for treatment of VVC/rVVC. Short- and long-term therapeutic efficacy of fluconazole was confirmed in numerous high reliability clinical trials. Good tolerance, wide range of single therapeutic dose and high level of patient's acceptance gives the specialist powerful and efficient tool for management of VVC/rVVC.


Assuntos
Antifúngicos/uso terapêutico , Candidíase Vulvovaginal/tratamento farmacológico , Complicações Infecciosas na Gravidez/tratamento farmacológico , Saúde da Mulher , Doença Aguda , Adulto , Candida/efeitos dos fármacos , Candidíase Vulvovaginal/microbiologia , Candidíase Vulvovaginal/prevenção & controle , Doença Crônica , Congressos como Assunto , Resistência Microbiana a Medicamentos , Feminino , Humanos , Capacitação em Serviço/normas , Programas Nacionais de Saúde/normas , Polônia , Gravidez , Complicações Infecciosas na Gravidez/microbiologia , Complicações Infecciosas na Gravidez/prevenção & controle , Garantia da Qualidade dos Cuidados de Saúde/normas , Recidiva , Sociedades Médicas/normas
12.
Ginekol Pol ; 79(1): 36-41, 2008 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-18510048

RESUMO

OBJECTIVES: The aim of this study was to analyze the changing trends in surgical treatment of female urinary incontinence (UI). MATERIAL AND METHODS: Medical records of all women admitted to II Department of Gynecology from 1985 to 2006 were analyzed in order to find out how the female SUI treatment changed over these years. RESULTS: During analyzed time 36819 patients were hospitalized in our Department and 77.6% (28568) of them were operated because of various indications. The number of SUI surgeries among all hospitalized women steadily rose from 1.93% in 1985 to 10.96% in 2006 reaching maximum in 2005 (13.73%). Clinical effectiveness of SUI surgeries markedly improved from 35% for anterior colporrhaphy to almost 90 % for suburethral slings. CONCLUSIONS: Introduction into clinical practice modern suburethral slings improved clinical efficacy of SUI treatment. The percentage of women admitted and treated surgically because of SUI steadily increased over the last years.


Assuntos
Satisfação do Paciente/estatística & dados numéricos , Slings Suburetrais/tendências , Incontinência Urinária por Estresse/epidemiologia , Incontinência Urinária por Estresse/cirurgia , Procedimentos Cirúrgicos Urológicos/tendências , Saúde da Mulher , Adulto , Feminino , Humanos , Estudos Longitudinais , Pessoa de Meia-Idade , Procedimentos Cirúrgicos Minimamente Invasivos/tendências , Polônia/epidemiologia , Polipropilenos/uso terapêutico , Complicações Pós-Operatórias/prevenção & controle , Estudos Retrospectivos , Slings Suburetrais/estatística & dados numéricos , Procedimentos Cirúrgicos Urológicos/métodos , Procedimentos Cirúrgicos Urológicos/estatística & dados numéricos
13.
Ginekol Pol ; 78(4): 299-302, 2007 Apr.
Artigo em Polonês | MEDLINE | ID: mdl-17621992

RESUMO

UNLABELLED: The prospective comparison of the clinical effectiveness and the complication rate of retropubic (IVS-02) and transobturator (IVS-04) midurethral slings in the treatment of female stress urinary incontinence. OBJECTIVES: The purpose of this study was the prospective comparison of clinical efficacy and safety of retropubic (IVS-02) and transobturator suburethral tape techniques (IVS-04) in the treatment of female stress urinary incontinence. MATERIAL AND METHODS: From January 2003 to June 2004, 145 patients with uro-dynamically proven stress urinary incontinence underwent surgical treatment (IVS-02 or IVS-04). During pretreatment work-up, all patients had under-gone full clinical and urodynamic evaluation. Patients with mixed, urge incontinence and the advanced urogenital prolapse (POPQ scale > 2) were excluded from the study. RESULTS: Patients clinical characteristics and urodynamic parameters were comparable between the analyzed groups. At one year follow-up, 122 patients (61 in each group) were evaluated in terms of clinical efficacy of the procedure. The total cure (78.7% in IVS-02 vs 70.5% in IVS-04), the improvement (14.7% vs 21.3%) and the failure rates (6.6% vs 8.2%) were similar in both analyzed groups, chi2 = 0.58; (p = 0.75). CONCLUSIONS: The transobturator route for the treatment of stress urinary incontinence appears to be as effective as the retropubic one at one year follow-up. Moreover, the shorter operation time and no need to perform cystoscopy during the surgery make the transoburator route a very attractive alternative to retropubic approach.


Assuntos
Slings Suburetrais , Uretra/cirurgia , Incontinência Urinária por Estresse/fisiopatologia , Incontinência Urinária por Estresse/cirurgia , Procedimentos Cirúrgicos Urológicos/métodos , Saúde da Mulher , Adulto , Feminino , Humanos , Pessoa de Meia-Idade , Procedimentos Cirúrgicos Minimamente Invasivos , Estudos Prospectivos , Implantação de Prótese , Resultado do Tratamento , Urodinâmica , Procedimentos Cirúrgicos Urológicos/efeitos adversos
14.
Eur J Obstet Gynecol Reprod Biol ; 124(1): 106-9, 2006 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-16026922

RESUMO

OBJECTIVE: Implantation of the mesh induces a foreign-body reaction followed by the development of connective tissue that may alter tape property. The aim of our study was to evaluate the deposition of collagen in the vicinity of monofilament tension-free vaginal tape (TVT; Ethicon Inc., Johnson & Johnson) and multifilament intravaginal slingplasty (IVS; Tyco Healthcare) polypropylene tapes implanted in female rats. METHODS: The samples of the meshes (10 mg each) were implanted in the rectus fascia of 14 Wistar female rats and removed after 42 days. Collagen was extracted with 0.5 M acetic acid and subsequently with pepsin (1 mg/ml in 0.5 M acetic acid). Collagen concentration was measured using Sircol Collagen Assay (Biocolor Ltd.) and normalised for milligrams of tape weight. For histological examination, tape samples were stained with haematoxylin and eosin or with silver for type III collagen. RESULTS: The total amount of collagen extracted did not differ significantly between TVT and IVS samples. For both tapes, extraction with acetic acid yielded a higher amount of collagen (about 70%) than extraction with pepsin. On histological examination, less densely packed bundles of collagen fibres and a slightly more intense inflammatory reaction were observed with TVT compared with IVS mesh. CONCLUSION: The total amount of collagen deposited around the polypropylene mesh implanted in female rats was similar for TVT and IVS meshes, but differences were noted in the arrangement of the collagen fibres and the intensity of the inflammatory reaction.


Assuntos
Colágeno/biossíntese , Reação a Corpo Estranho/etiologia , Animais , Materiais Biocompatíveis/normas , Tecido Conjuntivo/ultraestrutura , Feminino , Implantes Experimentais/normas , Inflamação/fisiopatologia , Polipropilenos/normas , Ratos , Ratos Wistar , Reto/efeitos dos fármacos , Telas Cirúrgicas/normas , Incontinência Urinária por Estresse/patologia , Incontinência Urinária por Estresse/cirurgia
15.
Int J Clin Exp Pathol ; 8(6): 7600-4, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26261676

RESUMO

Adenoma malignum (AM), also referred to as "minimal deviation adenocarcinoma", is an extremely uncommon variant of highly-differentiated adenocarcinoma of the uterine cervix. The study presented herein describes a case of uterine AM found out after hysteroscopy. An early-stage, well-differentiated mucinous uterine adenocarcinoma was diagnosed post-operatively. A subsequent immunohistochemical assessment of a panel of antibodies was applied, in order to distinguish between female genital tract malignancies.


Assuntos
Adenocarcinoma Mucinoso/química , Biomarcadores Tumorais/análise , Diferenciação Celular , Imuno-Histoquímica , Neoplasias Uterinas/química , Adenocarcinoma Mucinoso/patologia , Adenocarcinoma Mucinoso/cirurgia , Feminino , Humanos , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Valor Preditivo dos Testes , Resultado do Tratamento , Neoplasias Uterinas/patologia , Neoplasias Uterinas/cirurgia
16.
Cancer Genet Cytogenet ; 154(2): 186-9, 2004 Oct 15.
Artigo em Inglês | MEDLINE | ID: mdl-15474160

RESUMO

Components of the pRb1 pathway play a pivotal role in regulating the G1/S transition in the cell cycle. This study investigated the association between pRb1-cyclin D1-cdk4-p16INK4A pathway alterations and the clinical and prognostic utility for women affected by primary uterine endometrial adenocarcinoma (EC). The study population consisted of 50 cases of EC patients who were investigated for RB1 and CDKN2A (alias p16INK4A) gene alterations, as well as for the expression pattern of pathway proteins. Altogether, pRb1 pathway alterations were noted in 54% (27 of 50) of ECs, and more frequently in advanced-stage uterine carcinomas (P=0.024, Fisher exact test). Loss of heterozygosity abnormalities in RB1 and CKDN2A coexisted with altered cyclin D1-cdk4 complex immunoreactivity only in 2 patients, both less than 50 years of age. With respect to pRb1 pathway alterations, however, the recurrence rate was not significantly different (P=0.477; log-rank test). Our results suggest that the progression of uterine endometrial adenocarcinoma is generally accompanied by increased frequency of pRb1 pathway alterations. Alterations of the retinoblastoma pathway may not be necessarily associated with the recurrence of EC.


Assuntos
Proteína do Retinoblastoma/genética , Adenocarcinoma , Ciclina D1/genética , Quinase 4 Dependente de Ciclina , Quinase 6 Dependente de Ciclina , Quinases Ciclina-Dependentes/genética , Neoplasias do Endométrio , Feminino , Genes p16 , Humanos , Pessoa de Meia-Idade , Mutação , Prognóstico , Proteínas Proto-Oncogênicas/genética
17.
Contraception ; 69(6): 477-80, 2004 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-15157792

RESUMO

Resistin is a hormone secreted by adipose tissue that could be involved in the development of insulin resistance. Previous studies confirmed that endogenous sex steroids may influence serum resistin concentration in women. The aim of our study was to investigate the influence of combined oral contraceptives containing desogestrel or gestodene on circulating levels of resistin. Fifty-three women were enrolled in the study. Thirteen patients received 20 microg ethinylestradiol/150 microg desogestrel, 15 women were treated with 20 microg ethinylestradiol/75 microg gestodene, 11 with 30 microg ethinylestradiol/150 microg desogestrel and 14 with 30 microg ethinylestradiol/75 microg gestodene. Blood samples for estimation of serum resistin and insulin levels were drawn before administration of oral contraceptive and after 6 cycles of therapy. We found that serum resistin level remained unchanged in women receiving ethinylestradiol/desogestrel and was reduced in women treated with formulations containing gestodene. We conclude that ethinylestradiol combined with desogestrel or gestodene is unlikely to induce insulin resistance through resistin pathway.


Assuntos
Anticoncepcionais Orais Combinados/farmacologia , Hormônios Ectópicos/sangue , Adolescente , Adulto , Anticoncepcionais Orais Combinados/administração & dosagem , Desogestrel/administração & dosagem , Desogestrel/farmacologia , Etinilestradiol/administração & dosagem , Etinilestradiol/farmacologia , Feminino , Humanos , Insulina/sangue , Pessoa de Meia-Idade , Norpregnenos/administração & dosagem , Norpregnenos/farmacologia , Resistina , Resultado do Tratamento
18.
Ginekol Pol ; 74(9): 1018-22, 2003 Sep.
Artigo em Polonês | MEDLINE | ID: mdl-14674162

RESUMO

INTRODUCTION: Most characteristic symptom of overactive bladder is urgent, possibly painful, desire to void. This complaint is caused by autonomous bladder contractions. The increased activity of detrusor muscle is not only responsible for the urgency but also is the direct reason for the development of urge urinary incontinence. THE AIM OF THE STUDY: The comparison of the subjective (micturition diary) and objective (urodynamic investigation) mode of diagnosis of overactive bladder. MATERIAL AND METHOD: Twenty one women complaining of symptoms of the overactive bladder were included into the study. The infection of lower urinary tract was ruled out based on the results of urinalysis. Each patient reported urinary symptoms (number of urgency episodes and urge urinary leakages) in micturition diary for seven days. Thereafter, all participants underwent the urodynamic investigation that included uroflowmetry and cystometry. RESULTS: Data obtained from micturition diaries proved that all patients had subjective symptoms of overactive bladder (n = 21). However, only 8 subjects met overactive bladder diagnostic criteria on urodynamic investigation. The data obtained from micturition diaries and urodynamics were compared between group with objectively (urodynamic investigation) and subjectively (micturition diary) diagnosed overactive bladder. CONCLUSIONS: 1. There is marked discrepancy between data obtained from micturition diary and the results of urodynamic investigation. 2. It was shown that the diagnosis of overactive bladder cannot be made solely on the basis of maturation diary. 3. Volume of voided urine measured at uroflowmetry and volume of infused fluid causing strong desire to void are best markers of urodynamically proven diagnosis of overactive bladder.


Assuntos
Prontuários Médicos , Bexiga Urinaria Neurogênica/diagnóstico , Bexiga Urinaria Neurogênica/fisiopatologia , Incontinência Urinária/diagnóstico , Incontinência Urinária/fisiopatologia , Micção , Urodinâmica , Diagnóstico Diferencial , Feminino , Humanos , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Sensibilidade e Especificidade , Fatores de Tempo , Bexiga Urinária/fisiopatologia
19.
Ginekol Pol ; 74(10): 1410-4, 2003 Oct.
Artigo em Polonês | MEDLINE | ID: mdl-14669453

RESUMO

OBJECTIVES: The past decade has witnessed many publications indicating that estrogens play an important role in the function of the female lower urinary tract. Sex steroids receptors have been discovered in areas of the brain involved in the initiation and control of micturition, as well as other target tissues: bladder, urethra and pubocervical fascia. Connective tissue metabolism and collagen biosynthesis are modulated by ovarian steroids. Estrogen deficiency has been linked to the reduction of total vaginal and periurethral collagen content. Therefore, menopause and hypoestrogenism have been associated with several urogenital complaints including stress urinary incontinence (SUI), urgency, recurrent infection and genitourinary prolapse. DESIGN: The main purpose was to evaluate the proliferation ability of fibroblasts from pubocervical fascia after exposure to 17 beta-estradiol and phytoestrogen daidzein. MATERIALS AND METHODS: Specimens of human pubocervical fascia were obtained from 8 perimenopausal women during IVS procedure. Fibroblasts were isolated and cultured by outgrowth technique. After reaching confluency fibroblasts were subcultured every four days and cells after passage number 3 to 8 were used for assessment. Next day culture medium was changed and cells were exposed to serial dilutions of 17 beta-estradiol and daidzein in medium supplemented with only Serum Replacement 2. Cell proliferation was assessed after 96 hrs by means of MTT method. A human skin fibroblast culture served as a control. RESULTS: Pubocervical fascia fibroblasts showed increased proliferation capacity after 17 beta-estradiol than daidzein treatment. Proliferative activity of skin fibroblast was lower when compared to genitourinary cells in all groups investigated. CONCLUSIONS: The results indicate that, at least in vitro, fibroblasts from pubocervical fascia taken from women suffering from SUI are more capable to proliferate after estrogen treatment, when compared to skin fibroblasts. This is an indirect rationale for local estrogen treatment in case of female SUI.


Assuntos
Estradiol/farmacologia , Estrogênios não Esteroides/farmacologia , Fibroblastos/efeitos dos fármacos , Isoflavonas/farmacologia , Incontinência Urinária por Estresse/metabolismo , Adulto , Meios de Cultivo Condicionados , Estradiol/administração & dosagem , Terapia de Reposição de Estrogênios , Estrogênios não Esteroides/administração & dosagem , Fáscia , Feminino , Humanos , Técnicas In Vitro , Isoflavonas/administração & dosagem , Pessoa de Meia-Idade , Pele/citologia , Fatores de Tempo , Incontinência Urinária por Estresse/tratamento farmacológico , Incontinência Urinária por Estresse/prevenção & controle , Vulva
20.
Ginekol Pol ; 74(9): 1008-13, 2003 Sep.
Artigo em Polonês | MEDLINE | ID: mdl-14674160

RESUMO

OBJECTIVES: The "gold standard" in surgical treatment of stress urinary incontinence (SUI) is sling operation with polypropylene tape appliance under the mid urethra. There are two types of polypropylene tape which are the most popular nowadays. These two tapes are differently knitted so they have different biomechanical features. The TVT tape is monofilament, rarely knitted and highly elastic but the IVS mesh is multifilament, densly knitted and has only little possibility to stretch. The aim of our study was to assess the tissue reaction to the mono-(TVT) and multifilament (IVS) tapes. MATERIAL AND METHODS: The 10 mm x 10 mm pieces of TVT and IVS tapes were implanted inlay the fascia of musculus abdominis rectus of 14 rat females (2 groups of 7 animals). The tapes with the margin of surrounding fascia were taken off after 6 weeks of healing. All samples were fixed in 10% Formaldehyde in phosphate buffered saline and embedded in paraffin. Four micron tissue sections were stained with hematoxylin and eosin, the reticulin silver impregnation stain according to Gomori (for collagen type III) and periodic acid Schiff and alcian blue (for proteoglycan). RESULTS: In all sections filaments visible as elipsoids were surrounded by resorptive granulation with large multinucleated giant cells like around "foreign body". The diameter of monofilaments was about 150 microns. The connective tissue in the vicinity of mesh was rich of inflammatory cells like histiocytes, lymphocytes, a few polymorphonuclear leucocytes as well as adipocytes and fibroblasts. The large multinucleated giant cells adjacent to monofilaments were relatively bigger than these cells around multifilaments. Moreover, this granulation tissue has a lot of new blood vessels and collagenous fibrous tissue. The multifilaments were about 40 microns in diameter. The inflammatory granulation infiltrated aggregates of multifilaments. This tissue had only few inflammatory cells in comparison to tissue around monofilaments. The large multinucleated giant cells apposed to the mesh were small and collagen created thicker, more compacted bundles. CONCLUSION: The multifilament polypropylene tape induces weaker inflammatory tissue reaction than monofilament mesh. The thicker and more compacted collagen bundles are created around multifilaments so the natural tensile strength of the surrounding tissue is probably higher.


Assuntos
Implantes Experimentais/normas , Polipropilenos/normas , Telas Cirúrgicas/normas , Incontinência Urinária por Estresse/diagnóstico por imagem , Incontinência Urinária por Estresse/cirurgia , Animais , Materiais Biocompatíveis/normas , Feminino , Ratos , Fatores de Tempo , Resultado do Tratamento , Ultrassonografia , Incontinência Urinária por Estresse/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA